We are Sorry, This Page doesn't Exist

The gene sequencing equipment company announced strong quarterly results and still looks undervalued......»»

Shares of Pacific Biosciences of California (NASDAQ: PACB), a developer of systems for gene sequencing, are soaring to a two-year high in pre-market trading. read more.....»»

Sen. Gene Suellentrop has been charged with .....»»

Kansas Senate Majority Leader Gene Suellentrop faces the ch.....»»

The Kansas Highway Patrol arrested Gene Suellentrop in d.....»»

On CNBC's "Fast Money Final Trades," Jeff Mills said Illumina, Inc. (NASDAQ: ILMN) is a global leader in DNA sequencing with 70% share of the market. He is a buyer of the stock. read more.....»»

Illumina Inc. , which specializes in genetic testing and DNA sequencing, said Tuesday afternoon that its first-quarter revenue will be.....»»

Digital marketing is the buzzword of 2020. In fact, it wouldn’t be wrong to say that it has been the buzzword of the online world... The post How AI and Machine Learning Is Transforming Digital Marketing appeared first on ValueWalk......»»

When most investors and consumers think of antitrust issues and monopolies, they probably think of big giant multinational companies with billions of dollars in sales and assets and likely even........»»

Shares of Pacific Biosciences of California Inc. tumbled 3% in morning trading the day after the Federal Trade Commission announced plans to challenge Illumina Inc.'s plans to buy the genetic sequencing company. The regulator said Dec. 17 that Il.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Illumina: The Sequencing King Is Now On Sale.....»»

DNA sequencing and array-based technologies company Illumina, Inc. (NASDAQ: ILMN) pre-announced second-quarter resul.....»»

So say Gene Munster and Apple. But they've been wrong before......»»

Illumina Inc. shares rose in the extended session Friday after the DNA sequencing company and Bristol-Myers Squibb Co. announced they'll use Illumina's next-generation sequencing technology to develop cancer drugs at Bri.....»»

The company’s genomic data process and algorithmic tools have been licensed by more than 1,000 academic institutions and laboratories globally......»»

Shares of Illumina Inc. ran up 10.2% toward a record high, after the DNA sequencing company's better-than-expected second-quarter results prompted a host of analysts to raise their price targets. Of the 21 analysts surveyed by FactSet.....»»

The genome-sequencing company beat quarterly expectations and increased its full-year guidance last month. Here's what investors need to know......»»

Of course you wince whenever the phone rings. It's probably a machine, and there's a good chance it's trying to scam you......»»